查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1926878

全尺寸行动C臂市场（按购买类型、技术、应用和最终用户划分）－2026-2032年全球预测

Full-size Mobile C-arms Market by Purchase Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，全尺寸行动 C 型臂市场价值将达到 19.5 亿美元，到 2026 年将成长至 20.8 亿美元，到 2032 年将达到 31.7 亿美元，复合年增长率为 7.16%。

关键市场统计数据
基准年 2025 19.5亿美元
预计年份：2026年 20.8亿美元
预测年份 2032 31.7亿美元
复合年增长率 (%) 7.16%

对影响医疗服务环境中采用全尺寸移动式C型臂的当代临床和采购驱动因素进行清晰分析

本执行摘要总结了关于全尺寸移动式C臂机的关键观察结果，并阐述了影响其在现代医疗系统中应用和采购的技术、监管和临床趋势。随着临床团队寻求兼具精准成像和高效工作流程的设备，以及医疗系统优先考虑能够带来可衡量临床价值的资本投资，行动影像领域正在迅速发展。本文从设备外形规格、成像流程改进以及不同医疗环境下的营运需求等方面，对这些趋势进行了梳理。

检测器创新、软体生态系统以及门诊手术的兴起如何重塑移动影像系统的采购重点和临床期望

过去几年，一系列变革正在重塑消费者对全尺寸移动式C臂设备的期望，加速从旧有系统向模组化、软体驱动平台的过渡。平板检测器技术和先进影像处理演算法的进步提高了复杂介入手术中的诊断信心，同时实现了剂量降低策略，满足了日益严格的监管要求和病患安全期望。同时，製造商正在扩展其设备的软体生态系统，以促进影像整合、分析和远端支持，从而将临床价值提案到硬体效能之外。

评估供应链调整和筹资策略的最新趋势，以应对关税趋势，从而控制医疗影像诊断设备采购成本。

美国于2025年实施的政策变迁和关税措施引入了新的成本驱动因素，这些因素对全球医疗影像诊断设备的供应链产生了连锁反应。影响关键零件、子组件和成品的关税调整提高了部分进口产品的到岸成本，迫使采购团队重新评估其筹资策略，并与供应商就整体拥有成本进行更深入的讨论。这些关税的影响并非均匀分布，而是因零件产地、组装地点和合约条款而异。这意味着一些供应商自行承担了成本，而另一些供应商则将价格上涨转嫁给了客户。

详细的細項分析揭示了采购方式、临床环境、检测器选择和手术应用如何共同决定采购规格。

分析这种细分市场的细微差别，可以揭示购买类型、最终用户环境、检测器技术和临床应用如何相互作用，从而影响设备需求和购买行为。根据购买类型，市场分别针对全新产品和翻新产品进行考察，此差异会影响保固结构、软体升级合格和残值预期。安装新系统的机构通常期望获得多年服务协议和可预测的升级路径，而购买翻新产品的机构则往往优先考虑资金效率和即时可用性，同时接受在保固范围和长期软体相容性方面的妥协。

区域采购惯例、服务网络和监管差异如何影响全球医疗保健市场的采用模式和供应商策略

区域趋势对全尺寸移动式C臂系统的供应链配置、法规要求和临床应用模式有显着影响。在美洲，医院优先考虑互通性、剂量报告和完善的服务网络，并且通常期望获得延长的保固期和快速的现场服务，以支持高手术量的环境。相较之下，在欧洲、中东和非洲（EMEA），监管环境、报销框架和基础设施成熟度在不同地区差异显着，迫使供应商调整其产品和服务模式以满足国家和地区的具体要求。虽然EMEA部分地区对价格较为敏感，但三级医疗机构对先进影像功能的需求依然强劲。

分析供应商在硬体创新、售后服务和软体合作方面的策略，这些策略将影响行动成像领域的竞争格局。

製造商之间的竞争动态正朝着融合卓越硬体效能与软体支援服务模式的方向发展。领先的技术开发人员优先考虑提升检测器灵敏度、改进降噪演算法以及升级用户介面，以缩短检查准备时间。同时，差异化的售后服务，例如预测性维护分析、远距离诊断和结构化培训项目，正日益成为供应商价值提案的核心。影像设备製造商与软体供应商之间的策略联盟正在加速交付支援影像工作流程、剂量追踪和临床文件记录的整合解决方案。

经营团队可以采取切实可行的采购和临床整合步骤，以降低风险、提高运转率并最大限度地发挥行动成像投资的临床价值。

产业领导者可以采取以下几个切实可行的步骤，使其筹资策略和临床整合策略与当前的市场动态和业务重点保持一致。首先，组成跨职能团队，汇集临床、生物医学工程和供应链的专业知识，以明确反映预期用例和吞吐量目标的效能和服务要求。这种方法可以避免规范臃肿，并确保软体升级路径和备件供应保证等重要方面都包含在合约条款中。其次，优先要求供应商提供详细的总成本披露信息，包括服务响应时间、零件可用性和升级许可模式。这种透明度可以减少后续的采购纠纷，并有助于制定可预测的预算。

采用透明的混合调查方法，结合专家访谈、技术检验和监管审查，以确保为决策者提供可靠、可操作的见解。

本分析所依据的研究采用了严谨的混合方法，结合了一手资料和结构化的二手资料研究，以检验技术、临床和商业性的论点。一手资料研究包括对临床负责人、生物医学工程师、采购负责人和供应商产品经理的访谈，以获取关于设备性能、服务期望和购买因素的第一手资讯。这些定性研究结果辅以对设备规格、临床工作流程文件和供应商服务资料的观察性审查，以对所报告的功能进行三角验证。

总之，评估强调，影像效能、可维护性和采购过程的透明度相结合，是成功采用技术的关键因素。

总而言之，全尺寸移动式C臂正处于一个转折点，检测器精度、软体生态系统和售后服务的整合正在定义下一代临床能力。医疗机构越来越倾向于选择不仅成像性能卓越，而且维护性可预测，并能与临床工作流程无缝整合的系统。关税趋势和区域供应链动态增加了采购决策的复杂性，进一步凸显了明确的合约条款以及供应商对零件和升级服务的承诺的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按购买类型分類的全尺寸移动式C臂市场

  • 新的
  • 再生产品

9. 按技术分類的全尺寸移动式C臂市场

  • 平板检测器
  • 影像增强器

第十章 依应用分類的全尺寸移动式C臂市场

  • 循环系统
  • 胃肠病学
  • 整形外科
  • 泌尿系统

第十一章 以最终用户分類的全尺寸移动式C臂市场

  • 门诊手术中心
  • 诊断影像中心
  • 医院

第十二章：各区域全尺寸移动式C臂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 全尺寸移动式C臂市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国全尺寸移动式C臂市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国全尺寸移动式C臂市场

第十六章 中国全尺寸移动式C臂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Canon Medical Systems Corporation
  • DMS Group
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • OrthoScan, Inc.
  • Planmed Oy
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Villa Sistemi Medicali Spa
  • Ziehm Imaging GmbH
Product Code: MRR-4F7A6D4FF350

The Full-size Mobile C-arms Market was valued at USD 1.95 billion in 2025 and is projected to grow to USD 2.08 billion in 2026, with a CAGR of 7.16%, reaching USD 3.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.95 billion
Estimated Year [2026] USD 2.08 billion
Forecast Year [2032] USD 3.17 billion
CAGR (%) 7.16%

A clear framing of contemporary clinical and procurement drivers influencing full-size mobile C-arm adoption across healthcare delivery settings

This executive summary synthesizes critical observations on full-size mobile C-arms, describing the technological, regulatory, and clinical dynamics that are shaping adoption and procurement in contemporary healthcare systems. The landscape of mobile imaging is evolving rapidly as clinical teams seek devices that combine precision imaging with workflow efficiency, and as health systems prioritize capital investments that deliver measurable clinical value. This document frames those developments in the context of device form factors, image chain improvements, and the operational demands of diverse care settings.

The following analysis emphasizes how advances in detector technology, image processing, and user interface design are translating into new clinical capabilities across interventional specialties. It also highlights how provider priorities-such as procedure throughput, radiation dose management, and interoperability with electronic health records and PACS-are driving procurement specifications. Throughout, the narrative connects clinical imperatives with supply chain realities and procurement strategies to provide an integrated view useful to executives, clinical leaders, and sourcing professionals.

How detector innovations, software ecosystems, and outpatient procedural growth are reshaping procurement priorities and clinical expectations for mobile imaging systems

The past several years have seen a series of transformative shifts that are redefining what buyers expect from full-size mobile C-arms, and these shifts are accelerating the transition from legacy systems toward modular, software-enabled platforms. Advances in flat panel detector technology and smarter image processing algorithms have elevated diagnostic confidence for complex interventional procedures, while simultaneously enabling dose reduction strategies that satisfy growing regulatory and patient safety expectations. In parallel, manufacturers are expanding the software ecosystems of their devices to facilitate image integration, analytics, and remote support, which extends the clinical value proposition beyond pure hardware performance.

Operationally, there is a pronounced move toward devices optimized for hybrid environments and ambulatory procedural suites, where space constraints and workflow flexibility are paramount. This trend has been reinforced by the rising prevalence of outpatient and ambulatory surgical centers performing advanced endovascular and orthopedic procedures. Moreover, systems designed to minimize setup times and streamline documentation are gaining favor as providers seek to maximize throughput without compromising image quality. Taken together, these shifts point to a healthcare environment where adaptability, connectivity, and lifecycle serviceability are as important as raw imaging performance.

Assessment of recent tariff-driven supply chain adjustments and procurement strategies that are moderating cost exposure for medical imaging acquisitions

Policy changes and tariff actions implemented in the United States during 2025 have introduced new cost considerations that ripple across global supply chains for medical imaging equipment. Tariff adjustments affecting key components, subassemblies, and finished devices have increased landed costs for some imports, prompting procurement teams to re-evaluate sourcing strategies and to engage more closely with vendors on total cost of ownership. These tariff effects are not uniform; they vary by component origin, assembly footprint, and contractual terms, which means that some suppliers absorbed costs while others passed increases through to customers.

In response, vendors have accelerated efforts to localize manufacturing where feasible, diversify supplier networks, and redesign certain assemblies to use alternate components that are not subject to new duties. Buyers, for their part, have extended lead times and re-assessed service and spare parts agreements to mitigate exposure to sudden tariff-driven price variability. Clinicians and capital planners should note that while tariff impacts can be managed through procurement strategy, they increase the transactional complexity of purchases and emphasize the importance of clarity in total acquisition and lifecycle servicing commitments. Consequently, procurement professionals are placing higher value on transparent pricing, fixed-term service agreements, and supplier commitments to spare parts availability.

Detailed segmentation analysis revealing how purchase modality, clinical setting, detector choice, and procedural application collectively determine procurement specifications

A nuanced view of segmentation reveals how purchase modality, end user environment, detector technology, and clinical application intersect to shape device requirements and purchasing behavior. Based on Purchase Type, market is studied across New and Refurbished, and this distinction carries implications for warranty structures, software upgrade eligibility, and residual value expectations. Facilities acquiring new systems typically expect multi-year service contracts and predictable upgrade paths, whereas purchasers of refurbished units frequently prioritize capital efficiency and immediate availability, accepting trade-offs in warranty scope and long-term software compatibility.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals, a segmentation that highlights starkly different workflow and space constraints as well as varied clinical case mixes. Ambulatory surgical centers often prioritize compact footprint and rapid setup, diagnostic imaging centers emphasize throughput and cross-modality integration, and hospitals require versatile machines that can serve a broad range of interventional specialties. Based on Technology, market is studied across Flat Panel Detector and Image Intensifier, an axis that underscores differences in image quality, dose management, and cost-to-upgrade considerations. Flat panel detectors deliver improved spatial resolution and are increasingly preferred for complex interventional procedures, while image intensifiers remain relevant where budget constraints and legacy serviceability are key. Based on Application, market is studied across Cardiovascular, Gastroenterology, Orthopedic, and Urology, and this application-focused segmentation clarifies how modality-specific clinical workflows drive particular feature sets such as roadmapping for vascular work, c-arm angulation for spinal procedures, and special image processing modes for endoscopic-assisted interventions.

By synthesizing these segmentation vectors, procurement leads and clinical managers can better align specifications with intended use cases, anticipate service and training needs, and design acquisition strategies that reflect the interplay of capital constraints, clinical priorities, and expected device utilization.

How regional procurement practices, service networks, and regulatory diversity are determining adoption patterns and supplier strategies across global healthcare markets

Regional dynamics exert a powerful influence on supply chain configurations, regulatory expectations, and clinical adoption patterns for full-size mobile C-arms. In the Americas, health systems emphasize interoperability, dose reporting, and comprehensive service networks, and buyers often expect extended warranty and rapid field service to support high-volume procedural environments. Meanwhile, Europe, Middle East & Africa present a heterogeneous landscape where regulatory regimes, reimbursement frameworks, and infrastructure maturity vary considerably, prompting vendors to tailor product offerings and service models to country- or region-specific requirements. In parts of EMEA, price sensitivity coexists with strong clinical demand for advanced imaging features in tertiary referral centers.

Across Asia-Pacific, rapid hospital expansion, investments in tertiary care, and a burgeoning private hospital sector have driven demand for imaging platforms that balance advanced capability with cost-efficient servicing and local technical support. Regional pricing strategies, distributor networks, and local regulatory approvals shape product availability and deployment timelines across these geographies. Vendors that establish strong regional partnerships and invest in regional technical training and spare parts infrastructure tend to achieve more predictable uptake and higher customer satisfaction scores among institutional buyers.

An appraisal of vendor strategies showing how hardware innovation, aftermarket services, and software partnerships are shaping competitive positioning in mobile imaging

Competitive dynamics among manufacturers are converging toward a set of capabilities that combine hardware excellence with software-enabled services and support models. Leading technology developers have prioritized upgrades in detector sensitivity, noise reduction algorithms, and user interfaces that reduce procedure preparation time. At the same time, differentiated aftermarket offerings-such as predictive maintenance analytics, remote diagnostics, and structured training programs-are increasingly central to vendor value propositions. Strategic partnerships between imaging OEMs and software providers have accelerated the delivery of integrated solutions that support imaging workflow, dose tracking, and clinical documentation.

From a commercial standpoint, established global suppliers are leveraging their service footprints and financing programs to reduce purchasing friction, while niche and regional manufacturers compete on modularity, cost efficiency, and niche clinical feature sets. Several manufacturers have introduced refresh and refurbishment programs that extend device lifecycles and provide lower-cost entry points for budget-constrained buyers. Clinical leaders evaluating supplier options should weigh both the baseline imaging performance and the supplier's demonstrated capability to support ongoing software updates, training, and parts logistics over the expected lifespan of the device.

Practical procurement and clinical integration steps that executives can implement to reduce risk, improve uptime, and maximize the clinical value of mobile imaging investments

Industry leaders can take several practical steps to align their procurement and clinical integration strategies with current market dynamics and operational priorities. First, integrate cross-functional teams-combining clinical, biomedical engineering, and supply chain expertise-to define precise performance and service requirements that reflect intended use cases and throughput goals. This approach reduces specification creep and ensures that contractual terms cover essential aspects such as software upgrade pathways and spare parts commitments. Second, prioritize requests for detailed total cost disclosures from suppliers that include service response times, parts availability, and upgrade licensing models; clarity here reduces downstream procurement disputes and supports predictable budgeting.

Third, consider phased acquisition strategies that allow facilities to pilot newer detector technologies or refurbished units in lower-risk procedural areas before broader deployment. Fourth, negotiate fixed-term service levels and parts availability guarantees to mitigate exposure to supply chain volatility and tariff-related cost variation. Fifth, invest in training programs and remote support arrangements that shorten onboarding and maximize clinical utilization. By following these steps, hospital and clinic leaders can secure devices that deliver clinical value while minimizing operational disruption and unexpected lifecycle costs.

A transparent mixed methods research approach blending expert interviews, technical validation, and regulatory review to ensure robust and actionable insights for decision makers

The research underpinning this analysis was constructed through a rigorous mixed-methods approach combining primary engagements and structured secondary inquiry designed to validate technical, clinical, and commercial claims. Primary research included interviews with clinical leaders, biomedical engineers, procurement professionals, and vendor product managers to capture firsthand perspectives on device performance, service expectations, and purchasing drivers. These qualitative insights were complemented by observational reviews of device specifications, clinical workflow documentation, and vendor service literature to triangulate reported capabilities.

Secondary research encompassed regulatory guidance, standards for radiation safety and reporting, and publicly available technical literature on detector performance and imaging algorithms. Data synthesis included cross-referencing interview inputs with product literature and service contract terms to identify consistent patterns and divergent claims. Quality assurance measures included expert review cycles with clinical domain specialists and validation of technical assertions against manufacturer documentation. The methodology prioritized transparency in assumptions and sought to surface areas of uncertainty, enabling readers to interpret findings with appropriate context.

Concluding assessment emphasizing the convergence of imaging performance, serviceability, and procurement clarity as the decisive factors for successful technology adoption

In summary, full-size mobile C-arms are at an inflection point where detector fidelity, software ecosystems, and aftermarket services converge to define the next generation of clinical capability. Providers are increasingly selecting systems that offer not only superior imaging performance but also predictable serviceability and seamless integration with clinical workflows. Tariff developments and regional supply chain dynamics have added complexity to procurement decisions, reinforcing the value of explicit contractual terms and supplier commitments on parts and upgrades.

Looking ahead, success for clinical and purchasing leaders will depend on disciplined specification development, cross-functional decision making, and active engagement with suppliers on lifecycle support and cost transparency. Facilities that align device selection with precise clinical use cases and that secure robust service agreements will be best positioned to deliver high-quality interventional care while controlling operational risk and total lifecycle complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Full-size Mobile C-arms Market, by Purchase Type

  • 8.1. New
  • 8.2. Refurbished

9. Full-size Mobile C-arms Market, by Technology

  • 9.1. Flat Panel Detector
  • 9.2. Image Intensifier

10. Full-size Mobile C-arms Market, by Application

  • 10.1. Cardiovascular
  • 10.2. Gastroenterology
  • 10.3. Orthopedic
  • 10.4. Urology

11. Full-size Mobile C-arms Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals

12. Full-size Mobile C-arms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Full-size Mobile C-arms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Full-size Mobile C-arms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Full-size Mobile C-arms Market

16. China Full-size Mobile C-arms Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Canon Medical Systems Corporation
  • 17.6. DMS Group
  • 17.7. Fujifilm Holdings Corporation
  • 17.8. General Electric Company
  • 17.9. Koninklijke Philips N.V.
  • 17.10. Mindray Medical International Limited
  • 17.11. OrthoScan, Inc.
  • 17.12. Planmed Oy
  • 17.13. Shimadzu Corporation
  • 17.14. Siemens Healthineers AG
  • 17.15. Villa Sistemi Medicali Spa
  • 17.16. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY NEW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY NEW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY NEW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REFURBISHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REFURBISHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REFURBISHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GCC FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. G7 FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. NATO FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY PURCHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA FULL-SIZE MOBILE C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)